232 results on '"Oomen-de Hoop, E."'
Search Results
2. Appropriate medication use in Dutch terminal care: study protocol of a multicentre stepped-wedge cluster randomized controlled trial (the AMUSE study)
3. A review of trials investigating ctDNA-guided adjuvant treatment of solid tumors: the importance of trial design
4. Appropriate medication use in Dutch terminal care:study protocol of a multicentre stepped-wedge cluster randomized controlled trial (the AMUSE study)
5. Relation between body composition and severe diarrhea in patients treated with preoperative chemoradiation with capecitabine for rectal cancer: a single-centre cohort study
6. Esophagus toxicity after stereotactic and hypofractionated radiotherapy for central lung tumors: Normal tissue complication probability modeling
7. Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors
8. Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients
9. Quality of cancer treatment care before and after a palliative care pathway:bereaved relatives' perspectives
10. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases – the multicenter randomized controlled PUMP trial
11. The impact of therapeutic drug monitoring-based tamoxifen dose-reductions on endocrine side effects in patients with primary breast cancer
12. 27P Influence of single nucleotide polymorphisms (SNPs) in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer
13. 1142P The influence of food with different fat concentrations on alectinib exposure: A randomized cross-over pharmacokinetic trial
14. 1281P Impact of common germline variants on the toxicity profile and pharmacokinetics of alectinib
15. 1280P Effects of semaglutide on the exposure of alectinib in patients with NSCLC
16. 596P Dose-individualisation of fluoropyrimidines in DPYD wild-type patients: Final results from the Alpe2U study
17. Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium
18. Prevention of VEGF inhibitor-induced toxicity by salt restriction: the SUN-SALT study
19. 1863P Incidence and predictors of severe adverse events during anti-PD-1 treatment
20. Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients
21. Relation between body composition and severe diarrhea in patients treated with preoperative chemoradiation with capecitabine for rectal cancer:a single-centre cohort study
22. Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma:the multicentre prospective Safe Stop trial
23. Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients
24. 1154P Thromboembolic events in patients with melanoma receiving immune checkpoint inhibitors: Incidence and risk factors
25. 1589P Systemic treatment strategies and outcomes of patients with peritoneal metastases of gastric origin
26. Predicting overall survival in central NSCLC treated with SBRT: nomogram development and validation
27. The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma
28. Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study
29. Prognostic factors of local control and disease free survival in centrally located non-small cell lung cancer treated with stereotactic body radiation therapy
30. Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen
31. Influence of Cow’s Milk and Esomeprazole on the Absorption of Erlotinib: A Randomized, Crossover Pharmacokinetic Study in Lung Cancer Patients
32. Influence of genetic variation in COMT on cisplatin-induced nephrotoxicity in cancer patients
33. The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors
34. Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study
35. 191P Therapeutic drug monitoring of tamoxifen to improve adjuvant treatment of hormone sensitive breast cancer: The TOTAM study
36. 1851P The added value of the H2 blocker ranitidine in premedication regimens during paclitaxel treatment
37. 178 (PB-091) Poster - The impact of therapeutic drug monitoring-based tamoxifen dose-reductions on endocrine side effects in patients with primary breast cancer
38. Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer Patients
39. Circulating tumor cell enumeration and characterization in metastatic castration-resistant prostate cancer patients treated with cabazitaxel
40. Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study
41. Plasma Cell-Free DNA Testing of Patients With EGFR Mutant Non-Small-Cell Lung Cancer: Droplet Digital PCR Versus Next-Generation Sequencing Compared With Tissue-Based Results
42. A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients
43. The Effect of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in 400 Locally Advanced Cervical Carcinoma Patients
44. NTCP modelling of pulmonary toxicity after stereotactic radiotherapy for central lung tumors
45. Esophagus toxicity after stereotactic radiotherapy of central lung tumor: NTCP modelling
46. Effects of dietary restriction in cancer patients receiving irinotecan
47. Comparison of intratumoral docetaxel exposure in cancer patients between nanoparticle entrapped docetaxel (CPC634) and conventional docetaxel (Cd): The CriTax study
48. Influence of cow’s milk on the absorption and exposure of erlotinib in NSCLC patients
49. A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients
50. Influence of genetic variation in COMT on cisplatin-induced nephrotoxicity in cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.